Skip to content

Medical-device intelligence

JWY: Manual Antimicrobial Susceptibility Test Systems

FDA product code JWY: Manual Antimicrobial Susceptibility Test Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JWY
FDA device name
Manual Antimicrobial Susceptibility Test Systems
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

441 clearance records and 78 recall records in the covered releases, across 52 source company names and 1 product codes. Dated history runs from Feb 10, 1981 to Apr 21, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202510
November 202500
December 202500
January 202600
February 202600
March 202600
April 202620
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JWY · Manual Antimicrobial Susceptibility Test Systems44178

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

519 matching records
Device / recordCompany in FDA recordSourceSource date
ETEST Gepotidacin (GEP) (0.016-256 µg/mL)K260447 · JWYbioMérieux SA510(k)Apr 21, 2026FDA decision date
MTS Gepotidacin 0.016-256 µg/mLK260696 · JWYLiofilchem s.r.l.510(k)Apr 17, 2026FDA decision date
MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mLK252114 · JWYLiofilchem s.r.l.510(k)Oct 2, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mLK252062 · JWYThermo Fisher Scientific510(k)Sep 25, 2025FDA decision date
The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mLK250575 · JWYThermo Fisher Scientific510(k)Sep 5, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mLK252014 · JWYThermo Fisher Scientific510(k)Aug 28, 2025FDA decision date
MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD)K251580 · JWYLiofilchem s.r.l.510(k)Aug 20, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mLK250990 · JWYThermo Fisher Scientific510(k)Jun 30, 2025FDA decision date
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the d…K242843 · JWYThermo Fisher Scientific510(k)Jun 20, 2025FDA decision date
ETEST Aztreonam/Avibactam (AZA) (0.016/4-256/4 µg/mL)K250856 · JWYBiomérieux510(k)Jun 12, 2025FDA decision date
Thermo SCIENTIFIC Sensititre Cation Adjusted AutoRead Mueller-Hinton Broth w/ TES w/ Lysed Horse Blood, REF CP11410; invitro diagnostic deviceZ-1947-2025 · JWYRemel, IncRecallJun 11, 2025FDA classification date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mLK242659 · JWYThermo Fisher Scientific510(k)May 22, 2025FDA decision date
ETEST Imipenem/Relebactam P. aeruginosa (IRPA) (0.008/4-128/4 µg/mL)K250274 · JWYBiomerieux S.A.510(k)Apr 30, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mLK242658 · JWYThermo Fisher Scientific510(k)Apr 15, 2025FDA decision date
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilu…K242905 · JWYThermo Fisher Scientific510(k)Feb 10, 2025FDA decision date
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dil…K243201 · JWYThermo Fisher Scientific510(k)Feb 10, 2025FDA decision date
MTS Ceftobiprole 0.002-32 µg/mLK243202 · JWYLiofilchem s.r.l.510(k)Jan 30, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mLK243169 · JWYThermo Fisher Scientific510(k)Dec 19, 2024FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.25-32 ug/mLK242653 · JWYThermo Fisher Scientific510(k)Dec 5, 2024FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Daptomycin in the dilution range of 0.03-64 ug/mLK242657 · JWYThermo Fisher Scientific510(k)Nov 26, 2024FDA decision date
The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Meropenem in the di…K242021 · JWYThermo Fisher Scientific510(k)Oct 9, 2024FDA decision date
The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with ceftriaxone in the …K241967 · JWYThermo Fisher Scientific510(k)Oct 1, 2024FDA decision date
The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Imipenem in the dil…K240445 · JWYThermo Fisher Scientific510(k)May 16, 2024FDA decision date
Sensititre 20-24 hour Haemophilus influenzaelStreptococcus pneumoniae MIC or Breakpoint Susceptibility System with Ceftolozane-tazobactam in the …K232310 · JWYThermo Fisher Scientific510(k)Oct 31, 2023FDA decision date
ETEST® Sulbactam/Durlobactam (SUD) (0.004/4-64/4 µg/mL), ETEST® SUDK232395 · JWYBiomérieux510(k)Oct 5, 2023FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗